New research suggests that cytotoxic T cells are dominant in the lesional skin of patients with early diffuse cutaneous systemic sclerosis (SSc) and contribute to vasculopathy and tissue fibrosis. Could therapeutic strategies that prevent T cell activation and cytotoxicity therefore present an option to potentially halt progression of SSc?
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Current Concepts on the Pathogenesis of Systemic Sclerosis
Clinical Reviews in Allergy & Immunology Open Access 06 September 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Denton, C. P. & Khanna, D. Systemic sclerosis. Lancet 390, 1685–1699 (2017).
Maehara, T. et al. Cytotoxic CD4+ T lymphocytesmay induce endothelial cell apoptosis in systemic sclerosis. J. Clin. Invest. https://doi.org/10.1172/JCI131700 (2020).
Chizzolini, C. & Boin, F. The role of the acquired immune response in systemic sclerosis. Semin. Immunopathol. 37, 519–528 (2015).
Fuschiotti, P. et al. Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis. Arthritis Rheum. 65, 236–246 (2013).
Li, G. et al. Skin-resident effector memory CD8(+)CD28(-) T cells exhibit a profibrotic phenotype in patients with systemic sclerosis. J. Invest. Dermatol. 137, 1042–1050 (2017).
Ayano, M. et al. Increased CD226 expression on CD8+ T cells is associated with upregulated cytokine production and endothelial cell injury in patients with systemic sclerosis. J. Immunol. 195, 892–900 (2015).
McMahan, Z. H. et al. Enrichment of scleroderma vascular disease-associated autoantigens in endothelial lineage cells. Arthritis Rheumatol. 68, 2540–2549 (2016).
Boleto, G., Allanore, Y. & Avouac, J. Targeting costimulatory pathways in systemic sclerosis. Front. Immunol. 9, 2998 (2018).
Bosurgi, L. et al. Macrophage function in tissue repair and remodeling requires IL-4 or IL-13 with apoptotic cells. Science 356, 1072–1076 (2017).
Lederer, D. J. & Martinez, F. J. Idiopathic pulmonary fibrosis. New Engl. J. Med. 378, 1811–1823 (2018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Fuschiotti, P. T cells in SSc skin lesions: knowing your enemy. Nat Rev Rheumatol 16, 253–254 (2020). https://doi.org/10.1038/s41584-020-0404-6
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41584-020-0404-6
This article is cited by
-
Current Concepts on the Pathogenesis of Systemic Sclerosis
Clinical Reviews in Allergy & Immunology (2021)